Switch to:

Biomarin Pharmaceutical Research & Development

: $718 Mil (TTM As of Sep. 2019)
View and export this data going back to 1999. Start your Free Trial

This is the expense the company spent on research and development. Biomarin Pharmaceutical's research and development for the three months ended in Sep. 2019 was $173 Mil. Its research and development for the trailing twelve months (TTM) ended in Sep. 2019 was $718 Mil.


Biomarin Pharmaceutical Research & Development Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 461.54 634.81 661.91 610.75 696.33

Biomarin Pharmaceutical Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.41 175.39 183.59 185.64 172.96

Biomarin Pharmaceutical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2019 was 175.39 (Dec. 2018 ) + 183.591 (Mar. 2019 ) + 185.641 (Jun. 2019 ) + 172.963 (Sep. 2019 ) = $718 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Biomarin Pharmaceutical  (NAS:BMRN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Biomarin Pharmaceutical Research & Development Related Terms


Biomarin Pharmaceutical Research & Development Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */